PMA device
HeartMate II Left Ventricular Assist System
Abbott Medical · Ventricular (Assist) Bypass (DSQ, Class III) · First FDA decision May 7, 2010, newest May 29, 2026Heart failure
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
11
PMA pathway
Device trials
15
Naming "HeartMate II"
MAUDE reports
23,177
Brand "HeartMate II", since 2015
PubMed studies
1,149
Mentioning "HeartMate II"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing HeartMate II Left Ventricular Assist System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 11 decisions filed under this name.
- HeartMate II Left Ventricular Assist SystemPMA supplement
P060040-S123 · Decided May 29, 2026 · 109 days after receipt · Normal 180 Day Track
Device type: Ventricular (assist) bypass (DSQ) · Cardiology
- HeartMate II Left Ventricular Assist SystemPMA supplement
P060040-S115 · Decided May 23, 2025 · 81 days after receipt · Normal 180 Day Track
Device type: Ventricular (assist) bypass (DSQ) · Cardiology
- HeartMate II Left Ventricular Assist SystemPMA supplement
P060040-S091 · Decided Sep 29, 2023 · 179 days after receipt · Normal 180 Day Track No User Fee
Device type: Ventricular (assist) bypass (DSQ) · Cardiology
3 more FDA decisions with a free account
Older decisions: P060040-S060, P060040-S031, P060040-S023, P060040-S011, P060040-S010
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "HeartMate II", any status and sponsor, newest update first.
- Swedish Evaluation of Left Ventricular Assist Device as Permanent Treatment in End-stage Heart FailureActive, not recruiting
Vastra Gotaland RegionGovernment (non-federal)
NCT02592499 · 74 participants · Start Jun 2016 · Primary completion Oct 2026
Device: HM III · For: End-stage Heart Failure
Sites: Gothenburg, Sweden; Linköping, Sweden; Lund, Sweden · 7 sites in all
Hospices Civils de LyonAcademic, hospital or other
NCT04768322 · 92 participants (planned) · Start Feb 24, 2021 · Primary completion Feb 2029
Device: HeartMate 3 TM Left Ventricular Assist System · For: End-stage Heart Failure
Sites: Besançon, France; Bron, France; Caen, France · 8 sites in all
Abbott Medical DevicesPublic (ABT)
NCT03247829 · 101 participants · Start Aug 24, 2017 · Primary completion Mar 6, 2020
Device: Hemodynamic management using CardioMEMS HF System · For: Heart Failure
Sites: La Jolla, California; Los Angeles, California; San Diego, California · 23 sites in all
12 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "HeartMate II", and for the whole product code for context.
This brand
23,177 reports: 5,691 malfunction, 12,389 injury, 5,092 death
Whole product code DSQ
146,258 reports: 55,625 malfunction, 69,145 injury, 21,450 death
Newest reports for this brand
2916596-2026-2920542 · Received Oct 27, 2026 · Event dated Jul 21, 2020
Device type: Ventricular (Assist) Bypass (DSQ)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Atrial Fibrillation
2916596-2026-2920442 · Received Oct 22, 2026 · Event dated Oct 6, 2026
Device type: Ventricular (Assist) Bypass (DSQ)
Device problem as coded: Dull, Blunt
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2916596-2026-2920482 · Received Oct 21, 2026 · Event dated Dec 1, 2023
Device type: Ventricular (Assist) Bypass (DSQ)
Device problem as coded: Mechanical Problem; Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Thrombosis/Thrombus; Lactate Dehydrogenase Increased; Insufficient Information
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0507-2026 · Started Oct 9, 2025 · Posted by FDA Nov 14, 2025
Reason given: Due to potential corrosion issues associated with the Backup Battery cable connector that may cause a Backup Battery Fault Alarm.
Cause as FDA categorized it: Device Design · Device type: Ventricular (Assist) Bypass (DSQ)
Z-0508-2026 · Started Oct 9, 2025 · Posted by FDA Nov 14, 2025
Reason given: Due to potential corrosion issues associated with the Backup Battery cable connector that may cause a Backup Battery Fault Alarm.
Cause as FDA categorized it: Device Design · Device type: Ventricular (Assist) Bypass (DSQ)
Z-2290-2025 · Started Jun 23, 2025 · Posted by FDA Aug 13, 2025
Reason given: Due to misaligned V-Lock feature on the Mobile Power Unit power cords, which prevents the locking mechanism from properly engaging with the Mobile Power Unit and may cause unintended disconnect.
Cause as FDA categorized it: Vendor change control · Device type: Ventricular (Assist) Bypass (DSQ)
15 more recall records with a free account
Published research
The most relevant PubMed records for "HeartMate II"[tiab]. The summary above synthesizes these.
- Physiology and Clinical Utility of HeartMate Pump Parameters.
Belkin MN, Kagan V, Labuhn C, et al. · J Card Fail · 2022Review
- [Ventricular Assist Device].
Ono M · Kyobu Geka · 2017
- Axial flow blood pumps.
Song X, Throckmorton AL, Untaroiu A, et al. · ASAIO J · 2003Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- Recent advances in heart failure.
Kassi M, Hannawi B, Trachtenberg B · Curr Opin Cardiol · 2018Review
- Is it time to stop living in a HeartMate II world?
Yuzefpolskaya M, Fiedler AG, Katz JN, et al. · J Heart Lung Transplant · 2023Editorial
- [Implantable Ventricular Assist Device].
Nawata K, Ono M · Kyobu Geka · 2018Review
- The vexing problem of thrombosis in long-term mechanical circulatory support.
Mehra MR, Stewart GC, Uber PA · J Heart Lung Transplant · 2014Editorial, Introductory Journal Article
- Pump Position Impacts HeartMate II Left Ventricular Assist Device Thrombosis.
Kilic A, Ransom J, Maltais S, et al. · ASAIO J · 2019Research Support, Non-U.S. Gov't
- Clinical Courses of HeartMate II Left Ventricular Assist Device Thrombosis.
Kittipibul V, Xanthopoulos A, Hurst TE, et al. · ASAIO J · 2020
- New Treatments for Left Ventricular Assist Device-Associated Bleeding?
Strueber M · JACC Heart Fail · 2015Editorial, Comment
- Device exchange from Heartmate II to HeartWare HVAD.
Beaupre RA, Alnajar A, Sugiura T, et al. · J Card Surg · 2019
- Minimal-access left ventricular assist device explantation.
Cheung A, Soon JL · Innovations (Phila) · 2012
Other devices of this type
Also filed under product code DSQ.
- HeartWare® Ventricular Assist SystemMedtronic · PMA 2026
- HeartMate 3 Left Ventricular Assist SystemAbbott Medical · PMA 2026
- HeartWare HVAD SystemMedtronic · PMA 2026
- Thoratec Ventricular Assist Device (Vad)Thoratec Laboratories Corp. · PMA 2013
- CentriMag Circulatory Support SystemAbbott · PMA 2025
- EXCOR Pediatric Ventricular Assist DeviceBerlin Heart, Inc. · PMA 2026
- Thoratec Heartmate II Left Ventricular Assist SystemAbbott Medical · PMA 2017
- Abiomed Bvs 5000 Bi-Ventricular Support SystemAbiomed Cardiovascular, Inc. · PMA 2003
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.